Tuesday, September 23, 2014
Subscribe (News reader required)
- Bass Fishing Team Catches on at ESF
- ESF Faculty Member Contributes to Biogenic Carbon Report
- Onondaga Lake Bioblitz: More Than 400 Species in 24 Hours
- Governor Announces $20M Grant to ESF, Partners
- Forbes Ranks ESF 20th Nationwide for Best Value Colleges
Future of Biotechnology Focus of ESF Symposium
Two-day event includes tour of CNY Biotechnology Research Center
SYRACUSE, N.Y. - The future of biotechnology and a tour of the Central New York Biotechnology Center (CNY BRC) bio-incubator facility will be the focus of Biotechnology Symposium 2012 hosted by the SUNY College of Environmental Science and Forestry (ESF) in May.
This year's conference features two days of presentations, a tour of the new CNY BRC bio-incubator facility, more exhibitors than in previous years and an expanded student poster session.
Scheduled sessions are titled Bioenergy, Keys to Entrepreneurship and Innovation Success, Drug Delivery/Nanotechnology, Bioremediation, Fermentation: the Original Biotechnology, Biomaterials/Orthopedics, Agricultural Biotechnology, Biopharmeceuticals and Stem Cells/Tissue Engineering.
The CNY BRC is a joint project between ESF and Upstate Medical University. The 40,000-square-foot building will accommodate companies involved in the commercialization of medical and biological technologies.
Structural steel and foundation work is complete, and when open at the end of 2012, the facility will include 18 independent laboratory-office modules that will house more than 100 scientists, technicians and entrepreneurs and a full complement of business support services.
Symposium plenary sessions will be presented by Dr. Milena Adamian, director of Life Sciences Angel Networks; Heather Briccetti, president and CEO of the Business Council for New York State; Dr. Steve Goodman, vice president for research at SUNY Upstate Medical University; Dr. Cornelius B. Murphy, Jr., president of ESF; Dr. Karin Pavese, vice president of Innovation and Sustainability for the New York Academy of Sciences; Nancy Rurkowski, vice president of process sciences in biologics development at Bristol-Myers Squibb; Dr. David Smith, president of SUNY Upstate Medical University; and Dr. Todd Zion, founder and CEO of SmartCells.
Session speakers include experts from Brookhaven National Laboratory, British Petroleum, Stryker, and Corning Incorporated.
This year's symposium will be May 21 and 22 at the Oncenter Complex, Syracuse. For complete event information, visit www.esf.edu/outreach/pd/2012/biotechnology.Office of Communications
122 Bray Hall
1 Forestry Drive
Syracuse, NY 13210